ILOTYCIN Drug Patent Profile
✉ Email this page to a colleague
When do Ilotycin patents expire, and when can generic versions of Ilotycin launch?
Ilotycin is a drug marketed by Dista and is included in three NDAs.
The generic ingredient in ILOTYCIN is erythromycin gluceptate. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin gluceptate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ILOTYCIN?
- What are the global sales for ILOTYCIN?
- What is Average Wholesale Price for ILOTYCIN?
Summary for ILOTYCIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Patent Applications: | 4,132 |
| DailyMed Link: | ILOTYCIN at DailyMed |
US Patents and Regulatory Information for ILOTYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dista | ILOTYCIN | erythromycin | OINTMENT;OPHTHALMIC | 050368-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dista | ILOTYCIN GLUCEPTATE | erythromycin gluceptate | INJECTABLE;INJECTION | 050370-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dista | ILOTYCIN | erythromycin | TABLET, DELAYED RELEASE;ORAL | 061910-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
